🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT07369414
Recruiting Observational

Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households

NCT07369414 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2026-02-16
Last updated
2026-08-19

Condition(s) studied

Cystic Fibrosis (CF)MucoviscidosisNon-Tuberculous MycobacteriaMycobacterium Abscessus Infection

Investigational drug(s) / intervention(s)

Multi-modal NTM diagnostic including PCR, WGS, culture

Multi-modal NTM diagnostic including PCR, WGS, culture: Environmental samples from participants' households (e.g., water, dust, and soil) will be collected and tested for the presence of NTM. Analyses will be performed using PCR, culture-based methods, whole-genome sequencing (WGS), and subsequent bioinformatic analyses. In addition, available clinical NTM isolates from previous or future routine diagnostics will be included. If genomic sequencing has not yet been performed for these isolates, retrospective molecular genetic analysis (e.g., by WGS) will be conducted within the study to enable comparison with environmental isolates.

Study summary

This multicenter, non-interventional case-control study investigates whether household environmental reservoirs, particularly water systems, are associated with non-tuberculous mycobacterial (NTM) infections in people with cystic fibrosis (CF). Environmental samples from the homes of CF patients with and without NTM infection will be analyzed and genetically compared with available clinical isolates, alongside assessment of environmental risk factors, to improve understanding of exposure pathways and inform future prevention strategies.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Confirmed diagnosis of cystic fibrosis (CF) * No age restriction (including minors with consent from legal guardians) * Written informed consent to participate in the study (or consent provided by a legal guardian for minors) * In the case of an NTM infection: diagnosis according to ATS/IDSA criteria and availability of a clinical NTM isolate Exclusion Criteria: * Lack of capacity to provide informed consent, refusal to participate, or withdrawal of informed consent

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
National and WHO-Supranational Reference Center for Mycobacteria, Research Center Borstel, Leibniz Lung Center Borstel Schleswig-Holstein Recruiting
Klinik für Pneumologie, Universitätsklinikum Essen Essen Germany Not Yet Recruiting

More Research Center Borstel trials in Germany

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07369414 on ClinicalTrials.gov ↗ ← All trials in Germany